Company news
Kairos Pharma, Ltd. news in 2025
Kairos Pharma, Ltd.'s news releases, calls and decks from 2025, newest first.
Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer
December 17, 2025
Kairos Pharma Provides Shareholder Update
November 4, 2025
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
October 20, 2025
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
October 7, 2025
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
September 18, 2025
Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer
September 11, 2025
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025
September 3, 2025
Kairos Pharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
July 16, 2025
Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer
July 15, 2025
Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology 2025 Annual Meeting
June 4, 2025
Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
June 3, 2025
Kairos Pharma, Ltd. Announces Participation in the D. Boral Capital Inaugural Global Conference
May 6, 2025
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
April 28, 2025
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
Decks in 2025
- Corporate Update (September 2025)
Corporate update · 7 slides · Sep 18, 2025